Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY
Back to INO Full portfolio

Position in INO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$50
-$9,493 QoQ
Shares Held
46
-99.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 101 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,256,291 across 425 Biotechnology names. INO ranks #405 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in INO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50 46
2026-03-31 $9,543 5,485
2025-12-31 $73 42
2025-09-30 $152,580 65,206
2025-06-30 $7,526 3,690
2025-03-31 $28,737 17,631
2024-12-31 $21,856 11,944
2024-09-30 $67,936 11,754
2024-06-30 $91,270 11,296
2024-03-31 $6,565 473
2023-12-31 $6,884 13,500
2023-09-30 $24,243 62,165
2023-06-30 $1,358,315 3,018,482
2023-03-31 $2,684,732 3,274,067
2022-12-31 $5,112,084 3,276,979
2022-09-30 $5,706,033 3,298,286
2022-06-30 $5,943,327 3,435,451
2022-03-31 $12,352,537 3,440,819
2021-12-31 $18,951,409 3,797,878
2021-09-30 $29,411,981 4,107,819
2021-06-30 $31,861,507 3,437,056
2021-03-31 $14,658,436 1,579,573
2020-12-31 $9,705,341 1,096,649
2020-09-30 $7,293,452 628,746
2020-06-30 $16,110,007 597,774
2020-03-31 $3,311,579 445,105